Showing 4931-4940 of 5623 results for "".
- Retina Industry Giants Temporarily Extend Payment Termshttps://modernod.com/news/retina-industry-giants-temporarily-extend-payment-terms/2477512/Genentech, Regeneron, Allergan, and Novartis are extending payment terms in response to the COVID-19 crisis. George Williams, MD, discussed the terms of extended payment by Genentech and Regeneron on a recent episode of New Retina Radio, and the details were confirmed by statements from th
- Allergan COVID-19 Response: Program Enhancementshttps://modernod.com/news/allergan-covid-19-response-program-enhancements/2477507/Allergan has announced several program enhancements designed to assist eye care professionals and patients during the COVID-19 pandemic. These include: Lowering copay savings card offerings for Restas
- CAD4COVID: X-Ray Analysis for Quick Triage in Corona Crisishttps://modernod.com/news/cad4covid-x-ray-analysis-for-quick-triage-in-corona-crisis/2477508/Thirona and Delft Imaging launched CAD4COVID, a new artificial intelligence tool that analyzes X-ray images and is intended to support healthcare specialists manage COVID-19 cases. The companies
- Second Sight Announces Employee Layoffs, Intent to Wind Down Operationshttps://modernod.com/news/second-sight-announces-employee-layoffs-intent-to-wind-down-operations/2477503/Implantable visual prosthetics maker Second Sight Medical Products, announced that in response to the impact of the global COVID-19 pandemic on its ability to secure financing, the company decided to pursue an ord
- Immediate Surgery Combined with Injections for Submacular Bleeding May be Most Effective for Restoring Visionhttps://modernod.com/news/immediate-surgery-combined-with-injections-for-submacular-bleeding-may-be-most-effective-for-restoring-vision/2477499/The Mount Sinai Health System in New York announced the publication of a paper titled “Outcomes of pars plana vitrectomy with subretinal tissue plasminogen activator injection and pneumatic displacement of fovea-involving submacular haemorrhage” in the British Journal of Ophthalmology.</
- SECO International Names Dr. R. Max Raynor as 2021 Presidenthttps://modernod.com/news/seco-international-names-dr-r-max-raynor-as-2021-president/2477497/SECO International has named R. Max Raynor, OD, as the next president. His term began on March 7, 2020, and will last through February 28, 2021. Dr. Raynor officially accepted the honor during the House of Delegates meeting held on Saturday, March 7 at SECO 20/20. “Dr. Raynor has dedicated
- FDA Approves Anti-Malarial Drugs Chloroquine And Hydroxychloroquine For Emergency Coronavirus Treatmenthttps://modernod.com/news/fda-approves-anti-malarial-drugs-chloroquine-and-hydroxychloroquine-for-emergency-coronavirus-treatment/2477496/The Food and Drug Administration on Sunday issued an emergency authorization for experimental coronavirus treatments using chloroquine and hydroxychloroquine, anti-malaria drugs touted by President Donald Trump despite inconclusive clinical proof of their effectiveness, according to a Forbes
- OOTG Webcast: Weathering the Storm and Supporting Staffhttps://modernod.com/news/ootg-webcast-weathering-the-storm-and-supporting-staff/2477488/“Ophthalmology off the Grid” cohosts Gary Wörtz, MD, and Blake Williamson, MD, MPH, sat down—virtually—with Robert Weinstock, MD, and Elizabeth Yeu, MD, on March 27 to discuss how the COVID-19 crisis is
- Johnson & Johnson Announces a Lead Vaccine Candidate for COVID-19https://modernod.com/news/johnson-johnson-announces-a-lead-vaccine-candidate-for-covid-19/2477489/Johnson & Johnson announced a $1 billion deal with the U.S. government to create enough manufacturing capacity to make more than 1 billion doses of a potential vaccine for COVID-19. Johnson & Johnson said on Monday it has been working on a vaccine since January 2020 and expects to initiat
- The Allergan Foundation Donates $2 Million to Community Organizations on Front Line of COVID-19 Responsehttps://modernod.com/news/the-allergan-foundation-donates-2-million-to-community-organizations-on-front-line-of-covid-19-response/2477485/Allergan announced that The Allergan Foundation has awarded approximately $13 million in charitable grants in 2020. The 2020 donations support programs dedicated to the COVID-19 pandemic response, as well as initiatives supporting mental health, eye care, and breast